# OnCo record nct07408089 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07408089/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07408089", "NCT07408089" ;
  schema:name "Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer"@en ;
  schema:description "A phase 1 trial of BBI-940 run by Boundless Bio, Inc., terminated."@en ;
  schema:url <https://onco.cc/trials/nct07408089/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07408089> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/bbi-940/> ;
  onco:companies <https://onco.cc/companies/boundless-bio/> .